GW PHARMACEUTICALS PLC Financing Cash Flow
GW PHARMACEUTICALS PLC reported Financing Cash Flow of -$5.61 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-05-03
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was -$5.61M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was -$228.00K.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2020-09-30 was $746.00K.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2020-06-30 was -$1.43M, a 175.51% decline year-over-year.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2020 was -$1.13M, a 158.02% decline from fiscal 2019.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2019 was $1.95M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2018 was $297.75M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2017 was -$1.21M, a 100.44% decline from fiscal 2016.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$5.61M 10-Q · filed 2021-05-03 | -$5.83M derived: sum of 2 quarters · filed 2021-05-03 | -$5.09M derived: sum of 3 quarters · filed 2021-05-03 | -$6.52M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | -$228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $518.00K derived: sum of 2 quarters · filed 2021-02-26 | -$916.00K derived: sum of 3 quarters · filed 2021-02-26 | -$1.13M 10-K · filed 2021-02-26 |
| 2020-09-30 | $746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$688.00K derived: sum of 2 quarters · filed 2020-11-05 | -$901.00K 10-Q · filed 2020-11-05 | -$1.11M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$1.65M 10-Q · filed 2020-08-07 | -$1.86M derived: sum of 3 quarters · filed 2021-05-03 | -$2.06M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | -$213.00K 10-Q · filed 2021-05-03 | -$424.00K derived: sum of 2 quarters · filed 2021-05-03 | -$622.00K derived: sum of 3 quarters · filed 2021-05-03 | $1.28M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$409.00K derived: sum of 2 quarters · filed 2021-02-26 | $1.49M derived: sum of 3 quarters · filed 2021-02-26 | $1.95M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.70M derived: sum of 2 quarters · filed 2020-11-05 | $2.16M 10-Q · filed 2020-11-05 | $326.63M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.35M 10-Q · filed 2020-08-07 | $326.82M derived: sum of 3 quarters · filed 2021-02-26 | $327.25M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $456.00K 10-Q · filed 2020-05-11 | $324.92M derived: sum of 2 quarters · filed 2021-02-26 | $325.35M derived: sum of 3 quarters · filed 2021-02-26 | $325.14M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $324.47M 10-K · filed 2021-02-26 | $324.89M derived: sum of 2 quarters · filed 2021-02-26 | $324.69M derived: sum of 3 quarters · filed 2021-02-26 | $324.48M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $219.00K derived: sum of 2 quarters · filed 2019-11-06 | $11.00K 10-Q · filed 2019-11-06 | $297.75M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$412.00K 10-Q · filed 2019-08-07 | $297.33M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | -$208.00K 10-Q · filed 2019-05-08 | $297.54M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | $297.74M 10-K · filed 2021-02-26 | |||
| 2017-09-30 | -$1.21M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $274.26M 10-KT · filed 2019-02-28 |